
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1217 | 1034 | 1217 | 1412 | 1400 | 2629 |
Fund Return | 21.67% | 3.4% | 21.67% | 12.18% | 6.96% | 10.15% |
Place in category | 227 | 274 | 227 | 91 | 36 | 19 |
% in Category | 65 | 79 | 65 | 42 | 21 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AB FCP I AmericanGrwthPf N USD Acc | 8.53B | 23.76 | 4.96 | - | ||
American Growth Portfolio B Acu | 7.72B | 3.71 | 9.34 | 13.78 | ||
AB FCP I AmericanGrwthPf AD USD Inc | 8.3B | 25.76 | 6.99 | 14.51 | ||
AB FCP I AmericanGrwthPf SD USD Inc | 8.3B | 27.71 | 8.81 | 16.50 | ||
American Growth Portfolio AX USD Ac | 7.72B | 26.42 | 7.61 | 15.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Value Fund D2u | 140.51M | 9.33 | 13.01 | 6.24 | ||
LU0171281834 | 870.73M | 9.12 | 11.60 | 4.92 | ||
European Equity Portfolio S1X Acc | 326.37M | -11.16 | 3.85 | 8.24 | ||
European Equity Portfolio A Acc | 326.37M | -11.83 | 2.65 | 6.87 | ||
European Equity Portfolio C Acu | 326.37M | -12.06 | 2.19 | 6.40 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 5.29 | 89.24 | +0.22% | |
Roche Holding Participation | CH0012032048 | 4.88 | 303.10 | -1.37% | |
Royal Dutch Shell PLC B | GB00B03MM408 | 4.06 | - | - | |
ASM | NL0000334118 | 2.90 | 437.70 | -1.93% | |
Hugo Boss AG | DE000A1PHFF7 | 2.81 | 37.090 | -2.42% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review